Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
Meet Avance Clinical at the AACR Annual Meeting 2026 in San Diego.
Avance Clinical today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials.
Avance Clinical today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials.
Helping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower Costs, and Globally Accepted Data
Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence
Avance Clinical is proud to announce our attendance at the 10th Annual Outsourcing in Clinical Trials (OCT) Korea 2025, South Korea’s premier clinical outsourcing conference bringing together leaders in biotech and pharmaceutical innovation.
For European biotechs ready to move fast, Australia is the smartest early-phase starting point—and Avance Clinical is the CRO that makes it happen.
Avance Clinical will be exhibiting at the 13th Annual Outsourcing in Clinical Trials Southern California 2025, held on September 23-24 at the Hyatt Regency La Jolla at Aventine, San Diego.
This expert panel will explore how Australia, Taiwan, and South Korea provide a strategic advantage in conducting early, mid, and late-phase oncology trials, offering speed, cost efficiency, and global scalability.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com